【レポートの概要（一部）】
Table of Contents
Chapter 1 Research Methodology
1.1 Region Wise Market Calculation
1.1.1 Region Wise Market: Base Estimates
1.1.2 Global Market: CAGR Calculation
1.2 Region based segment share calculation
1.3 Data Analysis
1.4 List of Primary & Secondary Sources
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Pharmacogenomics Technology (Theranostics and Companion Diagnostics) Market Variables, Trends& Scope
3.1 Companion Diagnostics: Categorization
3.1.1 Screening and detection
3.1.2 Prognosis
3.1.3 Theranostics
3.1.4 Monitoring
3.1.5 Recurrence
3.2 Market Segmentation & Scope
3.2.1 Market Driver Analysis
3.2.1.1 Rising adoption of companion diagnostics
3.2.1.2 Accelerating demand for targeted cancer treatment & tailored drugs
3.2.1.2.1 Cancer incidence rate,2016
3.2.1.3 Technological advancements pertaining to sequencing
3.2.1.4 Collaborations between diagnostic and pharma entities
3.2.1.4.1 Business models that benefit CDx developers in early partnering deals
3.2.1.5 Growing healthcare expenditure triggering development of effective PM diagnostic & therapeutic procedure for cancer
3.2.2 Market Restraint Analysis
3.2.2.1 Challenges associated with reimbursement
3.2.2.2 Robustness of the financing environment for diagnostic and research tools companies
3.2.2.3 Laboratory developed tests anticipated to reduce adoption of CDx
3.3 Penetration & Growth Prospect Mapping for Therapeutic Area, 2016
3.4 Development of NGS based Companion Diagnostics
3.4.1 Associated operational challenges
3.4.1.1 Assay turnaround time
3.4.1.2 Sample quantity
3.4.1.3 Unavailability of CROs with CLIA NGS capabilities
3.4.2 Technical and analytical challenges for NGS assays in the clinic
3.4.2.1 Design & QC standardization
3.4.2.2 Post analytical challenges
3.4.2.3 Unavailability of CROs with CLIA NGS capabilities
3.4.3 Strategic challenges for drug and diagnostic developers
3.5 Companion Diagnostics Reimbursement Environment
3.5.1 Issues in technology assessment and payer decision making
3.5.2 Potential risks and benefits of pharmacogenomics from the payer perspective
3.6 Companion Diagnostics Regulatory Environment
3.6.1 Companion diagnostics regulatory environment, U.S.
3.6.2 Companion diagnostics regulatory environment, Europe
3.6.3 Companion diagnostics regulatory environment, Asia Pacific
3.7 Companion Diagnostics Regulatory Issues & Recall
3.7.1 Dako FDA warning letter
3.7.2 HercepTest recall
3.7.3 Cobas KRAS test recall
3.7.4 Cobas BRF V600E test recall
3.7.5 Leica Bond HER2 IHC system
3.8 Pharmacogenomics Technology (Theranostics and Companion Diagnostics) – SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.9 Industry Analysis – Porter’s
Chapter 4 Pharmacogenomics Technology: Therapeutic Area Estimates & Trend Analysis
4.1 Pharmacogenomics Technology (Theranostics and Companion Diagnostics) Market: Therapeutic Area Movement Analysis
4.2 Oncology
4.2.1 Global oncology market, 2014 – 2025 (USD Million)
4.2.2 Lung cancer
4.2.2.1 Global lung cancer market, 2014 – 2025 (USD Million)
4.2.3 Breast cancer
4.2.3.1 Global breast cancer market, 2014 – 2025 (USD Million)
4.2.4 Colorectal cancer
4.2.4.1 Global colorectal cancer market, 2014 – 2025 (USD Million)
4.2.5 Cervical cancer
4.2.5.1 Global cervical cancer market, 2014 – 2025 (USD Million)
4.2.6 Other cancers
4.2.6.1 Global other cancers market, 2014 – 2025 (USD Million)
4.3 Neurology
4.3.1 Global neurology market, 2014 – 2025 (USD Million)
4.4 Cardiovascular Diseases
4.4.1 Global cardiovascular diseases market, 2014 – 2025 (USD Million)
4.5 Immunological Disorders
4.5.1 Global immunological disorders market, 2014 – 2025 (USD Million)
4.6 Other Disorders
4.6.1 Global other disorders market, 2014 – 2025 (USD Million)
Chapter 5 Pharmacogenomics Technology: Technology Estimates & Trend Analysis
5.1 Pharmacogenomics Technology (Theranostics and Companion Diagnostics) Market: Technology Movement Analysis
5.2 Polymerase Chain Reaction(PCR)
5.2.1 Global polymerase chain reaction market, 2014 – 2025 (USD Million)
5.3 In-situ Hybridization
5.3.1 Global in-situ hybridization market, 2014 – 2025 (USD Million)
5.4 Immunohistochemistry
5.4.1 Global immunohistochemistry market, 2014 – 2025 (USD Million)
5.5 Sequencing
5.5.1 Global sequencing market, 2014 – 2025 (USD Million)
5.6 Other Technologies
5.6.1 Global other technologies market, 2014 – 2025 (USD Million)
Chapter 6 Pharmacogenomics Technology: Regional Estimates & Trend Analysis, by Therapeutic Area & Application
6.1 Pharmacogenomics Technology (Theranostics and Companion Diagnostics) Market Share by Region, 2016 & 2025
6.2 North America
6.2.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.2.2 Market, by technology, 2014 – 2025 (USD Million)
6.2.3 U.S.
6.2.3.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.2.3.2 Market, by technology, 2014 – 2025 (USD Million)
6.2.4 Canada
6.2.4.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.2.4.2 Market, by technology 2014 – 2025 (USD Million)
6.3 Europe
6.3.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.3.2 Market, by technology, 2014 – 2025 (USD Million)
6.3.3 Germany
6.3.3.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.3.3.2 Market, by technology, 2014 – 2025 (USD Million)
6.3.4 UK
6.3.4.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.3.4.2 Market, by technology, 2014 – 2025 (USD Million)
6.4 Asia Pacific
6.4.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.4.2 Market, by technology, 2014 – 2025 (USD Million)
6.4.3 Japan
6.4.3.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.4.3.2 Market, by technology, 2014 – 2025 (USD Million)
6.4.4 China
6.4.4.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.4.4.2 Market, by technology, 2014 – 2025 (USD Million)
6.5 Latin America
6.5.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.5.2 Market, by technology, 2014 – 2025 (USD Million)
6.5.3 Brazil
6.5.3.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.5.3.2 Market, by technology, 2014 – 2025 (USD Million)
6.6 MEA
6.6.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.6.2 Market, by technology, 2014 – 2025 (USD Million)
6.6.3 South Africa
6.6.3.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.6.3.2 Market, by technology, 2014 – 2025 (USD Million)
Chapter 7 Competitive Landscape
7.1 Strategy framework
7.2 Market participation categorization
7.3 Company Profiles
7.3.1 Illumina Inc.
7.3.1.1 Company Overview
7.3.1.2 Financial Performance
7.3.1.3 Product Benchmarking
7.3.1.4 Strategic Initiatives
7.3.2 F Hoffman La Roche
7.3.2.1 Company Overview
7.3.2.2 Financial Performance
7.3.2.3 Product Benchmarking
7.3.2.4 Strategic Initiatives
7.3.3 Qiagen NV
7.3.3.1 Company Overview
7.3.3.2 Financial Performance
7.3.3.3 Product Benchmarking
7.3.3.4 Strategic Initiatives
7.3.4 Myriad Genetics Inc.
7.3.4.1 Company Overview
7.3.4.2 Financial Performance
7.3.4.3 Product Benchmarking
7.3.4.4 Strategic Initiatives
7.3.5 Agilent Technologies
7.3.5.1 Company Overview
7.3.5.2 Financial Performance
7.3.5.3 Product Benchmarking
7.3.5.4 Strategic Initiatives
7.3.6 Foundation Medicine, Inc
7.3.6.1 Company Overview
7.3.6.2 Financial Performance
7.3.6.3 Product Benchmarking
7.3.6.4 Strategic Initiatives
7.3.7 Leica Biosystems Nussloch GmBH
7.3.7.1 Company Overview
7.3.7.2 Financial Performance
7.3.7.3 Product Benchmarking
7.3.7.4 Strategic Initiatives
7.3.8 Merck & Co Inc
7.3.8.1 Company Overview
7.3.8.2 Financial Performance
7.3.8.3 Product Benchmarking
7.3.8.4 Strategic Initiatives
7.3.9 Oxford Cancer Biomarkers Ltd.
7.3.9.1 Company Overview
7.3.9.2 Financial Performance
7.3.9.3 Product Benchmarking
7.3.9.4 Strategic Initiatives
7.3.10 Astra Zeneca
7.3.10.1 Company Overview
7.3.10.2 Financial Performance
7.3.10.3 Product Benchmarking
7.3.10.4 Strategic Initiatives
7.3.11 Thermo Fisher Scientific, Inc.
7.3.11.1 Company Overview
7.3.11.2 Financial Performance
7.3.11.3 Product Benchmarking
7.3.11.4 Strategic Initiatives
7.3.12 Beckman Coulter Inc.
7.3.12.1 Company Overview
7.3.12.2 Financial Performance
7.3.12.3 Product Benchmarking
7.3.12.4 Strategic Initiatives
7.3.13 Abbott Laboratories
7.3.13.1 Company Overview
7.3.13.2 Financial Performance
7.3.13.3 Product Benchmarking
7.3.13.4 Strategic Initiatives
7.3.14 Pfizer
7.3.14.1 Company Overview
7.3.14.2 Financial Performance
7.3.14.3 Product Benchmarking
7.3.14.4 Strategic Initiatives
7.3.15 Focus Diagnostics
7.3.15.1 Company Overview
7.3.15.2 Financial Performance
7.3.15.3 Product Benchmarking
7.3.15.4 Strategic Initiatives
7.3.16 AmeriPath Inc
7.3.16.1 Company Overview
7.3.16.2 Financial Performance
7.3.16.3 Product Benchmarking
7.3.16.4 Strategic Initiatives
7.3.17 Bristol Myers Squibb
7.3.17.1 Company Overview
7.3.17.2 Financial Performance
7.3.17.3 Product Benchmarking
7.3.17.4 Strategic Initiatives
7.3.18 Novartis Ag
7.3.18.1 Company Overview
7.3.18.2 Financial Performance
7.3.18.3 Product Benchmarking
7.3.18.4 Strategic Initiatives
【レポート販売概要】
■ タイトル：ファーマコゲノミクス技術/セラノスティクス/コンパニオン診断（CDx）の世界市場分析■ 英文：Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Analysis By Therapeutic Area (Oncology Neurological, Cardiovascular, Immunology Disorders), By Technology, And Segment Forecasts, 2014 - 2025
■ 発行日：2017年6月9日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW70714019
■ 調査対象地域：グローバル
- 局所はんだ付け装置の世界市場予測・分析2019-2023Global Selective Soldering Equipment Market: About this market Technavio’s selective soldering equipment market analysis considers sales from networking and communication, consumer electronics, automotive, medical, industrial, and instrumentation, and aerospace and defense in Europe, North America, South America, and MEA. In 2018, the networking and communication segment had a significant market s …
- 門脈高血庄症（Portal Hypertension）：グローバル臨床試験動向（2014年上半期）Portal Hypertension Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Portal Hypertension Global Clinical Trials Review, H1, 2014" provides data on the Portal Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Portal Hypertension. It includes an overview of the trial numbers and their recru …
- 感情分析の世界市場予測（～2024年）Global emotion analytics market size to grow at a CAGR of 15.8% during the forecast period The global emotion analytics market size to grow from USD 2.2 billion in 2019 to USD 4.6 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 15.8% during 2019–2024. Need for higher customer satisfaction, rising significance for real-time emotion analytics, adherence to regulatory and compliance stand …
- 世界のキラル分離カラム市場2015The Global Chiral Separation Column Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Chiral Separation Column industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Chiral Separation Column market analysis is provided for the international markets inclu …
- 乳がん治療薬の世界市場：モノクローナル抗体、ホルモン、化学療法、キナーゼ阻害剤、その他Breast Cancer Therapies – Discover From 2016 What Revenues Are PossibleAre you interested in the breast cancer drug market’s future? If so, you find that sales forecasting from 2016 in our new report. See there what is possible for those products and companies. You also explore trends, results and R&D, discovering opportunities and prospects. Visiongain’s study gives revenue predictions to 2026 at …
- 半導体IPの世界市場予測（～2023年）：プロセッサIP、インターフェースIP、メモリIPThe semiconductor intellectual property (IP) market is expected to be valued at USD 6.22 Billion by 2023, at a CAGR of 4.87% between 2017 and 2023. The factors such as the advancement in multicore technology for consumer electronics, increasing demand for modern SoC designs, and growing demand for connected devices are expected to drive the growth of semiconductor IP market. The consumer electroni …
- 世界の高性能コンピューティング・サーバー市場動向（2014-2018）TechNavio's analysts forecast the Global High-performance Computing Server market to grow at a CAGR of 7.78 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in Big Data. The Global High-performance Computing Server market has also been witnessing the emergence of cloud-based HPC solutions. However, the huge investment requirement could po …
- 世界の計装チューブ市場：エンドユーザー別、地域別Global Instrumentation Tubing Market: About this market Technavio’s instrumentation tubing market analysis considers sales from both process industry and discrete industry end-users. Our study also finds the sales of instrumentation tubing in APAC, Europe, MEA, North America, and South America. In 2019, the process industry segment had a significant market share, and this trend is expected to cont …
- スパイス（香辛料）の世界市場：唐辛子、カルダモン、シナモン、クローブ、コリアンダー、クミン、ジンジャー、ナツメグ、コショウ、ターメリックThe market for spices is observed to be growing at a low rate in developed economies such as Europe and North America as compared to developing companies due to the matured industrial sector in the former. The meat and poultry industry is still consuming the majority of spices and consumption will continue to grow at the healthy rate. As spices are the best natural preservatives and consumer prefe …
- 世界の排熱回収ボイラ（HRSG）市場（2014-2018）About Heat Recovery Steam Generators A heat recovery steam generator is a system used to extract useful heat from the exhaust of combustion turbines or hot gas streams. It has advantages over normal boilers in terms of resource efficiency and environmental friendliness. The steam extracted may be used by steam turbines to produce electricity. It can also be used for other factory processes such as …
- Filariasis：グローバル臨床試験レビューH1, 2013Filariasis Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Filariasis Global Clinical Trials Review, H1, 2013" provides data on the Filariasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Filariasis. It includes an overview of the trial numbers and their recruitment status as per the site of tri …
- ライフジャケット（救命胴衣）の世界市場2016-2020The global life jacket market is driven by a demand from coast guards and government marine agencies globally. Recreation is another key end-user segment, which demands life jacket for activities such as water skiing, fishing, and boating. Strong demand from APAC and European countries contribute significantly to market growth. Technavio’s analysts forecast the global life jacket market to grow at …
- 熱処理式空気ろ過の世界市場：熱酸化装置、再生熱酸化装置（RTO）、触媒酸化装置、再生触媒酸化装置（RCO）About Thermal Treatment Air Filtration Thermal treatment air filtration is a method of filtering exhaust gases generated by various industrial processes. The exhaust gases are heated to a very high temperature in the oxidizing chamber, thus breaking the bond between polluting compounds. The compounds then mix with the oxygen present in the chamber to form CO2 and H2O. It is suitable for removing h …
- 世界の高度ユーティリティボイラ（Utility Boiler）市場動向（～2019）The report estimates the advanced boiler market in terms of volume and value. The volume market is estimated in terms of the demand of energy per year. The report estimates the market size of the advanced boiler industry depending on the type of equipment such as subcritical boilers, supercritical boilers, ultra supercritical boilers, and others. This analysis is sub-divided into various geographi …
- 世界の核酸分離・精製市場動向（～2018）The global nucleic acid isolation and purification market is expected to witness a CAGR of 8.11% from 2013 to 2018. Nucleic acid isolation and purification is often the first step in most molecular biology techniques like cloning, sequencing, polymerase chain reaction (PCR), and others. These techniques find applications in fields like life science research, genetic engineering, molecular diagnost …
